6-Cyclohexylmethyl-3-hydroxypyrimidine-2,4-dione as an inhibitor scaffold of HIV reverase transcriptase: Impacts of the 3-OH on inhibiting RNase H and polymerase.

Citation data:

European journal of medicinal chemistry, ISSN: 1768-3254, Vol: 128, Page: 168-179

Publication Year:
Usage 28
Abstract Views 28
Captures 9
Readers 8
Exports-Saves 1
Social Media 2
Tweets 2
Citations 2
Citation Indexes 2
Tang, Jing, Kirby, Karen A, Huber, Andrew D, Casey, Mary C, Ji, Juan, Wilson, Daniel J, Sarafianos, Stefan G, Wang, Zhengqiang
Elsevier BV
Pharmacology, Toxicology and Pharmaceutics, Chemistry
Most Recent Tweet View All Tweets
article description
3-Hydroxypyrimidine-2,4-dione (HPD) represents a versatile chemical core in the design of inhibitors of human immunodeficiency virus (HIV) reverse transcriptase (RT)-associated RNase H and integrase strand transfer (INST). We report herein the design, synthesis and biological evaluation of an HPD subtype (4) featuring a cyclohexylmethyl group at the C-6 position. Antiviral testing showed that most analogues of 4 inhibited HIV-1 in the low nanomolar to submicromolar range, without cytotoxicity at concentrations up to 100 μM. Biochemically, these analogues dually inhibited both the polymerase (pol) and the RNase H functions of RT, but not INST. Co-crystal structure of 4a with RT revealed a nonnucleoside RT inhibitor (NNRTI) binding mode. Interestingly, chemotype 11, the synthetic precursor of 4 lacking the 3-OH group, did not inhibit RNase H while potently inhibiting pol. By virtue of the potent antiviral activity and biochemical RNase H inhibition, HPD subtype 4 could provide a viable platform for eventually achieving potent and selective RNase H inhibition through further medicinal chemistry.

This article has 0 Wikipedia mention.